Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis
Carcinogenesis, 07/31/09
Chung YL et al. – Epigenetic therapy using the HDAC inhibitor as an adjuvant to radiotherapy for chemical–induced oral cancer may provide a promising strategy combining the prevention of radiation–induced oral mucositis and the inhibition of oral carcinogenesis.
Related Articles
Oral cancer and polymorphism of ethanol metabolising genes
Oral Oncology, 11/12/09
Relevance Score: 70%
Quantification of betel quid chewing and cigarette smoking in oral cancer patients
Community Dentistry and Oral Epidemiology, 11/17/09
Relevance Score: 69%
Transactivation and expression patterns of Jun and Fos/AP-1 super-family proteins in human oral cancer
International Journal of Cancer, 11/10/09
Relevance Score: 68%
Saliva as a tool for oral cancer diagnosis and prognosis
Oral Oncology, 10/21/09
Relevance Score: 68%
Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer
Journal of Clinical Oncology, 10/16/09
Relevance Score: 68%
Today in Carcinogenesis...keeping you current
Receive free subspecialty "5-minute updates" via email
Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways
Endocrine-Related Cancer, 12/08/09
Activation of the hedgehog-signaling pathway in human cancer and the clinical implications
Oncogene, 11/30/09
Association of rare MSH6 variants with familial breast cancer
Breast Cancer Research and Treatment, 11/25/09
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Nuclear receptors in head and neck cancer: current knowledge and perspectives
International Journal of Cancer, 12/15/09
MicroRNA expression in head and neck cancer associates with alcohol consumption and survival
Carcinogenesis, 12/15/09
Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck
Carcinogenesis, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


